MedPath

Does Pregabalin Improve Post-operative Pain After C-section Delivery

Not Applicable
Completed
Conditions
Postoperative Pain
Interventions
Registration Number
NCT04259073
Lead Sponsor
Hôpital Universitaire Fattouma Bourguiba
Brief Summary

Pregabalin due to its antihyperalgesic effect, has proven its efficacy on neuropathic pain, essentially in nociceptive surgeries. Few studies have attempted to identify the utility of pregabalin as a premedication before cesarean delivery.

The investigators aimed to determine whether or not pregabalin as premedication improves analgesia post cesarean delivery.

Detailed Description

The investigators conducted a controlled, randomised, prospective and double-blind trial. One hundred thirty eight participants were included, with American Society of Anesthesiologists physical status classification of I to II, with pregnancies of at least 36 weeks of gestation who were scheduled for elective caesarean delivery under spinal anaesthesia. One hour before induction of anaesthesia participants received a capsule containing sugar placebo (placebo group), pregabalin 150 mg or pregabalin 300 mg. Data related to surgical history, pre-existing medical problems, indications for cesarean and peroperative hemodynamic changes were analyzed. The primary outcome was first analgesic request. Secondary outcomes included maternal pain scores at rest and during movement, rescue analgesics consumption, sedation, nausea, vomiting, pruritus and Apgar scores. All maternal secondary outcome variables were recorded 0, 2, 4, 6, 12, 18, and 24 h after delivery. Common side effects linked to pregabalin such as somnolence, blurred or abnormal vision, or fetal distress were collected.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
138
Inclusion Criteria
  • American Society of Anesthesiologists class I or II
  • single pregnancies at term
  • under spinal anesthesia
Exclusion Criteria
  • conversion to general anesthesia
  • post partum hemorrhage requiring specific resuscitation
  • local anesthetic toxicity
  • violation of the protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Group CPlacebostwo capsules filled with sugar
Group P300Pregabalin 300mgtwo capsules of pregabalin (150 mg)
Group P150Pregabalin 150mgtwo capsules; one of them containing sugar (like the placebo one), the other is the active drug (pregabalin 150 mg)
Primary Outcome Measures
NameTimeMethod
Time to first analgesic request24 hours

in minutes, the time between the end of the operation to the first demand of analgesics

Secondary Outcome Measures
NameTimeMethod
Visual disturbances24 hours post operatively

present or not

Visual analog scale (VAS) at rest and movement24 hours

Checked at hours 2, 4, 6,12,18 and 24 post operatively

Maternal satisfaction24 hours

Measured by a Visual Analog Scale, ranging from 0 to 100; 0=not satisfied at all

Heart ratePer operative period

beats per minute

Maternal consumption of paracetamol postoperatively24 hours

grams

Ramsay score for sedation24 hours post operatively

Ranging from 1 to 6

Apgar scores1 and 5 minutes after birth

Ranging from 0 to 10; 7 to 10 correspond to an excellent condition

Non-invasive blood pressurePer operative period

measured in millimeters of mercury

Fluids administered to the mother per operativelyPer operative period

in milliliters

Dose of ephedrine administered to the mother per operativelyPer operative period

in milligrams

Trial Locations

Locations (1)

Monastir maternity and neonatology center

🇹🇳

Monastir, Tunisia

Monastir maternity and neonatology center
🇹🇳Monastir, Tunisia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.